CStone Pharmaceuticals (HK:2616) has released an update.
CStone Pharmaceuticals has announced a board meeting scheduled for August 23, 2024, to discuss and approve its unaudited interim financial results for the first half of the year and to consider declaring an interim dividend. The meeting will be an important event for the company and its subsidiaries as they evaluate their mid-year financial performance.
For further insights into HK:2616 stock, check out TipRanks’ Stock Analysis page.